• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STIMWAVE TECHNOLOGIES INC. FREEDOM NEUROSTIMULATOR; SPINAL CORD NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STIMWAVE TECHNOLOGIES INC. FREEDOM NEUROSTIMULATOR; SPINAL CORD NERVE STIMULATOR Back to Search Results
Model Number FR8A-RCV-A0
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Pain (1994); Skin Inflammation/ Irritation (4545)
Event Date 02/17/2021
Event Type  Injury  
Manufacturer Narrative
The clinical representative followed-up on the occurrence with the implanting clinician to gain more information.The implanting clinician stated that the patient had been admitted to the hospital to control the pain.On (b)(6) 2021, the clinical representative visited the patient at the hospital.On this date, the clinical representative learned that the implanting clinician had explanted the left lead (a-lead) on (b)(6) 2021.The clinical representative reprogrammed the b-lead, which was not explanted following the implanting clinician's parameters.The clinical representative reported that the patient was released from the hospital on (b)(6) 2021.The patient-reported that she was feeling better following the removal of the lead and the irritation is now in control.The patient also reported feeling relief after the reprogramming session.The clinical representative set 3 programs based on her tonic response and set it to program one.The clinical representative sat with the patient for 15 minutes after turning on program one, and the patient-reported good pain relief in the desired area.Clinical representative confirmed that the implant procedure was performed in a sterile environment with sterile field handling protocols, sterile barriers of all products used were intact before the implant, and the procedure was completed in accordance with the product instructions for use.A stimwave representative conducted a review of sterilization and packaging records for the respective product lot; stimwave has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.Based on this information, the irritation/discomfort was confirmed/replicated.There is no evidence that the product did not meet specifications, and the stimulator is used to treat pain.The cause of the irritation/discomfort is unknown/no problem found.Design (b)(4) were reviewed, and irritation and discomfort are known issues with mitigation controls in place to reduce risk as far as possible therefore, no capa is required.Stimwave's global new pain rate: (b)(4) stimwave's global skin irritation rate: (b)(4).
 
Event Description
On (b)(6) 2021, the clinical representative became aware that a recently implanted patient had been admitted to the hospital due to pain, irritation, and discomfort following the implant procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREEDOM NEUROSTIMULATOR
Type of Device
SPINAL CORD NERVE STIMULATOR
Manufacturer (Section D)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer (Section G)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer Contact
andrea najera
1310 park central boulevard s.
pompano beach, FL 33064
8009655134
MDR Report Key11543922
MDR Text Key257278252
Report Number3010676138-2021-00051
Device Sequence Number1
Product Code GZB
UDI-Device Identifier00818225020693
UDI-Public010081822502069317211001
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other
Type of Report Initial
Report Date 02/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/22/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/01/2021
Device Model NumberFR8A-RCV-A0
Device Lot NumberSWO191025
Was Device Available for Evaluation? No
Date Manufacturer Received02/20/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-